To describe the effect of endogenous dopamine on [11C]raclopride binding, we previously extended the conven tional receptor ligand model to include dynamic changes in neurotransmitter concentration. Here, we apply the extended model in simulations of neurotransmitter competition studies using either bolus or bolus-plus-infusion (B/I) tracer delivery.
Abbreviations used: BII. bolus plus infusion; Bma" total receptor den sity; BP, binding potential; CE Q , equilibrium concentration; C,(t). tissue time-activity curve; CM1N, minimum tracer concentration; C p ' plasma con centration; D.C. percent change in total tissue concentration; Db dopa mine-2 receptor; 12 . tissue free fraction; H. peak of N,(t); K,. plasma to-tissue influx constant; kb tissue-to-plasma clearance rate in the ab sence of nonspecific binding; Kii . neurotransmitter atIinity; kOff' receptor dissociation rate; kon. bimolecular association rate; N,(t), free neurotrans mitter concentration; PET, positron emission tomography; R, clearance rate of N,(t); SPECT, single photon emission computed tomography; V. volume of distribution; Ve. distribution space of free plus nonspecifical ly bound tracer; V=. ratio of tissue and plasma integrals; D. V, percent change in total distribution volume; Vio. early Logan slope; V�oo. late Logan slope. 1196 cent reduction in tissue concentration (�C) after neurotrans mitter release was calculated. Both � V and �C were strongly correlated with the integral of the neurotransmitter pulse. The values of � V and �C were highly dependent on the kinetic properties of the tracer in tissue, and � V could be characterized in terms of the tissue free tracer concentration. The value of � V was typically maximized for binding potentials of -3 to 10, with �C being maximized at binding potentials of -I to 2. Both measures increased with faster tissue-to-blood clearance of tracer and lower nonspecific binding. These simulations pro vide a guideline for interpreting the results of neurotransmitter release studies and for selecting radiotracers and experimental design. Key Words: Compartmental modeling-Receptor binding-Neurotransmitters. aI., 1991; Innis et aI., 1992; Volkow et aI., 1994; Laruelle et aI., 1997) . In these studies of neurotransmitter com petition, tracer is delivered either as two bolus injections, i.e., control and stimulus (Logan et aI., 1991) , or as a single bolus plus infusion (B/I) (Carson et aI., 1997) . With either delivery method, the change in tracer binding caused by a change in neurotransmitter level can be mea sured. With these techniques, tracers with different ki netic characteristics (e.g., high or low binding affinity), have shown sensitivity to endogenous neurotransmitter. Measurement of the dynamic neurotransmitter concen tration in vivo has shown more directly that a change in tracer binding is caused by a change in neurotransmitter level. Microdialysis of the rat striatum showed that either an increase or decrease in neurotransmitter concentration corresponds to an opposing change in e 1 C]rac1opride binding observed in primate PET studies using the bolus technique (Dewey et aI., 1995) . Simultaneous measure ment of dopamine and [ ll Clrac1opride in combined mi crodialysis-PET studies in monkeys similarly showed a decrease in [ ll Clrac1opride binding after amphetamine stimulated dopamine release in BII studies (Endres et aI., 1997) . Furthermore, a larger amphetamine dose pro duced a larger increase in dopamine, and a larger percent decrease in [ ll C]raclopride concentration (Breier et aI., 1997) . These results suggest that a measured change in tracer binding may provide quantitative information about the underlying neurotransmitter pulse.
To better interpret studies of neurotransmitter compe tition, it would be useful to characterize the relation be tween changes in tracer binding and neurotransmitter re lease. Logan et al. (1991) considered the effect of a do pamine pulse on the distribution volume of C 8 Fj-N methylspiroperidol in bolus injection studies. The dopamine pulse was defined by its initial peak and clear ance rate. Compared to a control study (i .e., with no dopamine pulse), simulations showed that a larger peak and a slower dopamine clearance rate resulted in a larger change in the tracer uptake rate as measured by graphical analysis. Furthermore, the largest effect occurred when the dopamine pulse was initiated simultaneously with tracer injection. Morris et ai . (1995) performed simula tions to determine the kinetic characteristics of a D2 li gand that would have maximal sensitivity to a transient increase in dopamine. In this study, the effect of the dopamine pulse was evaluated as the sum of the squared differences in time-activity curves between a control study and a dopamine release study. From this measure, it was proposed that a completely irreversible tracer gives maximum response to a dopamine pulse.
Recently, combined PET-microdialysis experiments were performed that gave simultaneous measurements of C l C]raclopride and extracellular dopamine in rhesus monkeys (Breier et ai., 1997) . Bolus-plus-infusion tracer delivery was used with amphetamine challenge to induce dopamine release. The data were used to extend the con ventional receptor ligand model to describe the effect of endogenous dopamine on the binding of [11 C]raclopride (Endres et ai ., 1997) . Initial simulations using the ex tended model showed that the change in [1 1 C]raclopride concentration measured with the BII method is propor tional to the integral of the amphetamine-induced dopa mine pulse. This result provides a basis for the interpre tation of a measured change in e l C]raclopride concen tration in terms of dopamine release.
In this paper, we further apply the extended model in simulations of both the bolus and BII methods to predict the effect of neurotransmitter competition for receptor binding tracers with different kinetic properties. A wide range of tracer kinetic parameters was simulated cover ing established reversible PET tracers. Two specific is sues were addressed: (1) determining an appropriate in terpretation of the measured change in tracer binding in terms of dynamic changes in neurotransmitter concen tration; and (2) examining how the kinetic characteristics of the tracer, i.e., binding constants, delivery, and non specific binding, affect the sensitivity to neurotransmitter concentration .
METHODS

Study overview
The model used for simulations ( Fig. I) was developed by extending the conventional two-tissue compartment model for [IIClraclopride (Farde et aI., 1989) . One compartment repre sents tracer that is free or nonspecifically bound, and the second compartment represents specific binding to receptors. It is as sumed that nonspecifically bound tracer is in rapid equilibrium with free tracer. The extended model also assumes rapid equi librium between free and bound neurotransmitter, and that neu rotransmitter binds at a single affinity. The model parameters are K I (mL'min-I'mL-I), the plasma-to-tissue influx constant;
k; = 12k2 (min-I), where k2 is the tissue-to-plasma clearance rate in the absence of nonspecific binding, and 12 is the tissue free fraction (Mintun et aI., 1984) ; k�(t) = 12k,(t), with kit) = konBmaJ(l + Nf(t)IK�) (min-I), where kon is the bimolecular association rate (L'nmol-I'min-I), Bmax is the total receptor density (nmollL), Nf(t) is the free neurotransmitter concentra tion (nmollL), and K� is the neurotransmitter affinity (nmoIlL); and k4 = koff (min-I), the receptor dissociation rate. Note that the presence of a time-varying neurotransmitter pulse (Nit» causes the tracer binding rate k�(t) to be time-dependent (En dres et aI., 1997). The product of kon and Bmax was treated as a single parameter because high specific activity of the tracer was assumed. Hypothetical tracers were simulated by varying the kinetic parameters. The simulations were limited to tracers that are sufficiently reversible to permit measurement of the distribution volume within a 2-hour time frame. The effect of a neurotransmitter pulse was tested with tracer delivered either via bolus injection or 8/!'
Simulations
To simulate a variety of hypothetical tracers, a range of kinetic parameters was chosen based on the published kinetics of several reversible PET ligands, including [IICjraclopride (Farde et aI., 1989) , [I I Clflumazenil (Koeppe et aI., 1991) , and [IKF]cyclofoxy (Carson et aI., 1993) . The range of parameters tested was K I = 0.1 to 1.0 mL'min-I'mL-I, Ve, the distribu tion space of free plus nonspecifically bound tracer or K/k;. K/k; = 0.3 to 6.0 mLlmL, km,smax = 0.1 to 1.0 min-I , and knIT = 0.02 to 0.25 min-I. Neurotransmitter pulses were mod eled as monoexponential curves [NI{t) = Hexp( -Rt)] with the peak of Nit), H = 0.5 K� to 2 K�, is the neurotransmitter affinity and the clearance rate of Nr(t), R = 0.04 to 0.1 min-I.
These values for H and R are based on values obtained for amphetamine-induced dopamine pulses in rhesus monkeys, as measured with microdialysis (Endres et aI., 1997) . From simu lations that accompanied those studies, we calculated that base line dopamine levels had little effect on measured changes in
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FIG. 1. Two-tissue compartmental model to describe neurore ceptor ligand binding. The two compartments represent free and nonspecific tracer (Cf), and specific binding to receptors (Cb). The plasma-tissue exchange constants across the blood-brain bar rier are Kl and k�, the free plus nonspecific volume of distribution is Ve = Kllk�, k3(� is the receptor binding rate, and k4 = koff is the dissociation rate. Because neurotransmitter competes with tracer for neuroreceptor binding, the tracer binding rate (k'3(t» is time dependent when the neurotransmitter concentration varies with time.
the specific binding of e IC]raclopride. Thus, in these simula tions, baseline neurotransmitter level, and hence baseline re ceptor occupancy, was assumed to be zero. Overall, three to seven values of each parameter were chosen as follows: K I : 0. 1, 0.2, 0.5, 1.0 mL'min-I'mL-I; Ve: 0.3, 0.6, 1.0, 3.0, 6.0 mLlmL; konBmax: 0. 1,0.2,0.5, 1.0 min-I; koff: 0.02,0.04,0.06, 0.08, 0. 1,0. 15, 0.25 min-I; H: 0.5 K�, K�, 2 K� nmolJL; R: 0.04, 0.06, 0. 1 min-I. Time-activity curves were simulated us ing all possible parameter combinations. This generated 560 simulated tracers, 9 simulated neurotransmitter pulses, and more than 5,000 simulated curves for both the bolus and BII methods. To better characterize the relation between neuro transmitter release and the radioligand measurements, select tracers were tested with a larger range of neurotransmitter pulses: H = 0.375 K� to 2.5 �, and R = 0.03 to 0. 15 min-I. The selected tracers included those at the extremes of the simu lated range (i.e., tracers having various combinations of the smallest or largest values of k�, f2konBmax, and koff)' All simu lations were performed without addition of noise. Preliminary simulations showed that including a 4% blood volume had negligible effect on the results; consequently, intravascular ra dioactivity was ignored.
Bolus method
With bolus tracer delivery, two separate studies are per formed to measure neurotransmitter competition (Logan et aI., 199 1) . One study is a control, during which the neurotransmit ter concentration is assumed to be constant. The second study includes a stimulus (e.g., amphetamine) that induces neuro transmitter release. In experiments with the bolus method, the total volume of distribution (V) is measured for each study, and the percent change in specific binding (i.e., binding potential) between the control and stimulus studies is calculated to quan titate the effect of the neurotransmitter pulse. However, it is important to recognize that the fraction of V contributed by specific binding will vary across different tracers. For example, a tracer may give a large absolute change in specific binding that corresponds to a small change in the V. Therefore, in this simulation study, from signal-to-noise considerations, the per cent change in V will be used as a measure of changes in neurotransmitter concentration (see Discussion).
Simulations of the bolus method were performed using a smoothed metabolite-corrected C IC]raclopride plasma input function from a rhesus monkey. Tissue time-activity curves (C;(t» were generated from the extended two-compartment model without noise using a fourth-order Runge-Kutta algo rithm (Press et aI., 1992) with a step size of 0.025 minute for 120 minutes, and larger (up to 1 minute) step sizes thereafter.
To simulate PET studies, mean values of the time-activity curves were calculated for a scan protocol of 6 x 30 seconds, 3 x 60 seconds, 2 x 120 seconds, 4 x 300 seconds, 8 x 150 seconds, 10 x 300 seconds, 2 x 600 seconds, for a total scan duration of 120 minutes. For each hypothetical tracer (i.e., each combination of K], Ve, konBmax, and koff)' a control curve (i.e.,
with Nit) = 0) was generated in addition to the stimulus curves [NrCt) = Hexp(-Rt)]. For the stimulus curves, the neu rotransmitter pulse was initiated coincident with the bolus in jection (see Discussion). The effect of the neurotransmitter pulse was assessed by computing the percent reduction in V between the stimulus study and the control study.
The following methods were used for calculation of V with the bolus method: (1) The slope as measured by Logan graphi cal analysis with plasma input computed using data from 20 to 60 minutes after injection ('10).
(2) Because graphical analysis requires sufficient time to measure an accurate slope, data from 60 to 100 minutes (VLoo) were used to determine whether the slope measured at a later time would differ from the result obtained in method (1). (3) A one-compartment, two-parameter (K I , k'D model (Koeppe et aI., 199 1) was fit (un weighted) to 120 minutes of data, and the distribution volume (V I ) was estimated from Kllk'�, (4) A two-compartment, four-parameter (K I , k;, k�, k4) model was fit (unweighted) to 120 minutes of data, and the distribution volume (V2) was estimated from K/k;( 1 + k�/k4)' (5) The ratio of the tissue and plasma integrals (Vx) was calculated as follows (Lassen and Perl, 1979) :
Methods (1) through (4) used the simulated PET time activity curves, with the time frames chosen to correspond to the duration of a study with a IIC or 18F-labeled tracer. To ensure accurate calculation of equation 1, tissue time-activity curves were simulated for an extended duration (more than 10,000 minutes). To perform this calculation, the input function from 5 to 90 minutes was fit to a sum of three exponentials, and then extrapolated. The percent change in the total distribution volume (Ll V) between control and stimulus studies was esti mated using each method.
It is not clear a priori whether methods (1) through (5) would give similar estimates of the distribution volume, because the presence of a time-varying neurotransmitter pulse causes the distribution volume (V(t» to be time-dependent. Therefore, in the stimulus study, the measured distribution volume cannot be interpreted as a fixed value. Theoretical relations between the measured distribution volumes and Vet) are derived in the dis cussion and appendices. To determine the consistency of the distribution volume estimates between methods, the percent difference and correlation of V and Ll V were determined for each pair of methods using the simulation data.
Bolus-plus-infusion method
Bolus-plus-infusion tracer delivery is used to achieve equi librium in plasma and tissue (Carson et aI., 1993) . After equi librium is attained, a change in neurotransmitter level produces a change in tissue tracer concentration. An advantage of the B/I method over the bolus method is that the effect of a neuro transmitter pulse can be determined in a single study.
For simulations of the B/I method, it was assumed that tracer equilibrium in plasma and all brain regions was initially achieved. The input function C p was assumed to be constant throughout the study, and the initial tissue activity was set to the equilibrium level CE Q ' where CE Q = (K/k;) . (1 + f2konBmaJkoff)C p . Then, using the monoexponential neuro transmitter pulse and the differential equations of the extended model, the free and bound tracer concentrations were simu lated. The neurotransmitter pulse was initiated, causing the tracer concentration to decrease, achieve a minimum value (C M 1 N ), then increase toward the original equilibrium level ( Fig. 2) . Because the minimum concentration corresponds to dC/dt = 0, then, from the model differential equations, at that time Cf = (K/k�)Cp, i.e., the free plus nonspecific concentra tion is identical to that during the initial equilibrium level, if C p and Kllk� are unchanged. Therefore, the change from the initial concentration to the minimum concentration is entirely because of a change in specific binding. For this reason, the maximum percent reduction in tissue concentration (LlC) was used to evaluate the effect of the neurotransmitter pulse, i.e., Typical tissue time-activity curve simulated with the bo lus-plus-infusion method. The initial concentration of the simula tion was set to the equilibrium level CEQ, where CEQ = Ve( 1 + f2konBrna,)ke tt )Cp. Cp is the plasma level at equilibrium, ken is the bimolecular association rate, B rnax is the total receptor density, Ve = K11k; is the free plus nonspecific volume of distribution, and ke tt is the dissociation rate. After equilibrium, a neurotransmitter pulse was initiated causing the tracer concentration to decrease, achieve a minimum value (CM1N), then increase toward the origi nal equilibrium level. The sensitivity to the neurotransmitter pulse was computed from the maximum percent reduction in concen
Note that AC is the percent change in the total tissue concen tration, as opposed to the percent change in specific binding that is typically measured in PET or SPECT studies. This is analogous to using the total distribution volume in bolus studies (see Discussion).
Analysis
It was previously shown that the extended model predicts that a change in specific [l IClraclopride binding, measured with the BII protocol, is proportional to the integral of the dopamine pulse normalized by the neurotransmitter affinity (IN/t)IKg) (Endres et aI., 1997) . Normalization by Kg is nec essary because the model is only sensitive to the ratio of free neurotransmitter to its affinity. To determine whether this in terpretation is appropriate for other tracers and for both the bolus and B/I methods, we initially tested for linear correlation between A V or AC and (INtCt)/K�). However, the simulations showed that these relationships often became nonlinear as the neurotransmitter pulse became large because of saturation ef fects. Therefore, the Spearman rank correlation, which does not assume a particular functional form, was used to determine whether a monotonic relation exists between A V or AC and JNtCt)/Kg. For initial testing of the correlation, Nr(t) was inte grated for 40 minutes on the basis of our previous results with [ ll C]raclopride (Endres et aI., 1997) . To determine the effect of the integration interval of INlt) on the correlation between A V or AC and INlt)IKg, Nit) was also integrated for times of 10, 20, 30, 60, 80, and 100 minutes. The correlations of A V and AC with Ha nd R were also tested.
The simulations were examined to determine how tissue-to blood transport, receptor density, receptor dissociation rate, binding potential, and nonspecific binding affected the magni tude of A V and AC, i.e., the sensitivity to neurotransmitter release. Note that we have defined the binding potential as k�/k4 = f2kenBrnaJkorr' i.e., the equilibrium ratio of bound to free plus nonspecifically bound tracer. Because the parameter K1 scales the entire time-activity curve, it also scales the estimate of Ci and V. Consequently, varying the value of K1 did not affect the calculation of percent changes A V and AC. There fore, the sensitivity to a neurotransmitter pulse can be charac terized in terms of k20 f2' konBmax, and kOff' To determine the relation between A V or AC and tissue-to-blood transport, the effect of changing k2 was examined with the remaining param eters held fixed. The relation with receptor density was studied by varying konBmax, and the relation with receptor dissociation rate or binding potential was evaluated by varying kOff' To test the relation with nonspecific binding, we examined the effect of changing f2 so that k;(f2k2) and k�(f2k3) were varied with k�1 k; held unchanged.
RESULTS
Bolus studies
Estimation of V and Ll V. Table 1 shows the mean and SD of the percent differences in the distribution volume estimates calculated by the five different methods. The small mean values of the percent differences «2%) for all measures except the one-compartment fit (Vj) indi cate that equation I (V,,, ), the Logan slope (vtO, vLOO) , and the two-compartment fit (V 2) give similar estimates of V even in the presence of a neurotransmitter pulse. From examination of the standard deviations of the per cent differences, it is seen that in comparison to the "early" Logan slope (vI°), the "late" Logan slope (VLoo) was in better agreement with both V2 and V". This result is supported theoretically, because it can be shown that the Logan slope measured at an increasingly late time converges to Vee (see Discussion). Further exami nation of the percent differences in V revealed that all estimates were in better agreement with each other as koff increased. For example, the mean ± SD of the percent differences between V 2 and Voo was 3.0% ± 7.2% with koff = 0.02 min-I , but only -0. 1 % ± 0.5% with koff = 0.25 min-I . The mean ± SD of the percent differences between \!f0 and vLoO was 0.5% ± 9.1 % for koff = 0.02 min-I , and -0.8% ± 2.7% for koff = 0.25 min-I . The smaller standard deviation for koff = 0.25 min-I , indi
cates that the estimates given by vto and vLoO are more consistent at the faster dissociation rate. This suggests that for tracers with rapid dissociation rates, a shorter scan time is sufficient for quantification of the graphical analysis slope. Inspection of the effects of k 2 and konBmax did not reveal a pattern in the percent differences of the estimates. The one-compartment fit estimate (VI) was the least consistent with the other methods, with a mean percent difference more than or equal to 5.1 % and large SD. Apparently, in many cases the one-compartment model is not an adequate approximation to the extended model used to generate the data. Relation between Ll V and the integrated neurotrans mitter pulse. Figure 3 shows examples of the relationship between Ll V and the integrated neurotransmitter pulse (fNt<t)/K�, with Nr(t) integrated for 40 minutes) for four tracers with different kinetics. Across all the simulated tracers (n = 560), the linear correlation between Ll V and fNt<t)/K� was 0.93 ± 0.08. For more than 80% of the tracers, the linear correlation was greater than 0.9. How ever, for tracers with very slow clearance rates (e.g., k; = 0.0166 min-I , f 2 konBmax = 1.0 minl ,a nd kof[ = 0.02 min-I ), the correlation was smaller, with the lowest value being r = 0.64.
In general, the relation between Ll V and fNrCt)/K� did not remain linear for large pulses because of receptor saturation effects ( Fig. 3) . Therefore, linear correlation may not be appropriate for characterization of the rela-tion between Ll V and JNt<t)/K�. Therefore, we calculated the Spearman rank correlation, which does not depend on an assumed functional form. The Spearman correlation gave similar results to the linear correlation, i.e., r greater than 0.9, except for tracers with very slow clearance rates. This indicates that for any tracer with kinetics within the range tested here, the larger the integral of the neurotransmitter pulse, the larger the Ll V. Integration of Nr(t) for longer than 40 minutes (up to 100 minutes) had little effect on the correlation. In general, the correlation of Ll V with either H or R was much smaller than the correlation of Ll V with fNt<t)/K�. For tracers with large kb the correlation of Ll V with H was as large as 0.91;
however, this was still smaller than the correlation be tween Ll V and fNJ:r)/K�. Effect of tracer kinetic characteristics on Ll V. Figure 4 shows Ll V for a range of konBmax and ko ff values, plotted as a function of konBmax ( Fig. 4A ), ko ff (Fig. 4B ), and binding potential ( Fig. 4C ). For a given ko[[' Ll V was maximized at a particular value of konBmax ( Fig. 4A ), i.e., the tracer is maximally sensitive to neurotransmitter changes at a particular receptor density. Alternatively, for a fixed value of konBmax, Ll V is maximized with a tracer having a particular dissociation rate (Fig. 4B ). For small konBmax (e.g., low receptor density), a tracer with small koff (slow dissociation) gave the best contrast (larg est Ll V), whereas a larger koff value provided best con trast when konBmax was large. Thus, tracers giving good contrast had similar binding potentials ( Fig. 4C ). There fore, the binding potential appeared to be a more useful parameter than either konBmax or ko ff to characterize the sensitivity of a tracer to neurotransmitter changes, and was subsequently used to describe the simulation results. Note that in many cases, a wide range of binding poten tial values produced very similar Ll V values. Figure 4C also shows that at a given binding potential, a tracer with low receptor density (and therefore, small koff) will yield a slightly larger Ll V than a tracer with a high receptor Effects on the percent reduction in distribution volume (�\I) of (A) tissue-to-blood clearance (k2), and (8) nonspecific binding (f2)' Bolus studies were simulated with Nj(t) = �exp(-0.06Q and koff= 0.02 to 0.25 min-1. In Fig. 5A , f2 = 1 and konBmax = 0.5 min-1. In Fig. 5B , konBmax = OA min-1 and k2 = OA min-1. Faster tissue-to-blood clearance and less nonspecific binding produce higher � V.
sensitive to changes in neurotransmitter concentration when using the bolus method.
Bolus-plus-infusion
Relation between LlC and the integrated neurotrans mitter pulse. Figure 6 shows examples of the relation between the maximum change in tracer concentration (AC) from B/I studies and fNr<t)IK� (with Nr<t) integrated for 40 minutes), for four tracers with different kinetics.
The linear correlation between AC and fNr<t)IK� was very strong for all 560 simulated tracers (r = 0.96 ± 0.04). As was found for Ll V, LlC usually does not in crease linearly at the highest values of fNt<t)IK� because of saturation effects. Therefore, the Spearman rank cor relation was calculated, which showed excellent correla tion between AC and fNf(t)IK� (r ?o 0.95) for all tracers.
The correlation value was somewhat dependent on the integration interval, although the effect was minor. How ever, it is interesting to note that the integration interval that gave the highest correlation corresponded to the time at which tracer concentration reached its minimum value (CM1N, Fig. 2) . Thus for tracers that were rapidly dis placed, AC showed higher correlation with the 20-minute integral of Nf(t) than it did with the 80-minute integral.
J Cereb Blood Flow Metab, Vol. 18, No. 11, 1998 This could be expected, because after the mlmmum tracer concentration has been reached, the subsequent neurotransmitter concentration does not influence the measurement of AC. Despite this effect, the Spearman correlation was always large (i.e., r ?o 0.92 for integra tion intervals from 20 to 80 minutes). Therefore, for any tracer with kinetics in the range tested here, a larger change in tracer concentration (LlC) can be interpreted as a larger neurotransmitter pulse integral, and this inter pretation is not sensitive to the integration interval. For all other tracers tested, AC showed better correlation with fNf(t)IK� than H or R, as was previously reported for [ ll C]raclopride kinetics (Endres et aI., 1997) . When both k 2 and koff were large, the correlation of LlC with H was as large as the correlation of AC with fNt<t)IK�.
Effects of tracer kinetic characteristics on AC. Figure   7 shows three simulated BII curves for tracers that have identical kinetics except for different values of ko f f, giv ing binding potentials (BP = f2konBmaxlkoff) of 0.8, 3, and] O. The dotted curve (koff = 0.25, BP = 0.8) shows that when the receptor dissociation rate is fast, the tracer closely follows the transient neurotransmitter pulse and returns quickly to its initial concentration after clearance of neurotransmitter. At a slower dissociation rate (koff = 0.067, BP = 3, dashed curve), the tracer is displaced more slowly but gives a larger LlC because of the larger specific binding fraction (75% at BP = 3 versus 44% at BP = 0.8). At an even slower dissociation rate (koff = 0.02, BP = 10, solid curve), tracer is displaced very slowly, and reaches a minimum concentration at a later time when much of the neurotransmitter has already cleared. Thus, although this tracer has the highest spe cific binding fraction (91 %), it does not show the highest fractional displacement. Figure 8 shows the profile of AC displayed versus BP.
As was found with A V (Fig. 4C ), the value of AC is maximized at a particular value of BP, i.e., the relation ship of AC and konBmax or koff alone is more scattered as in Figs. 4A and B . Therefore, the BP is a more useful parameter to predict AC than either konB rn ax or koff ' How ever, LlC was maximized at BP (l to 2) that were smaller than those that maximized A V. This could reflect the importance of rapid dissociation for the B/I method, as larger koff values correspond to smaller BP. At a given BP, there was a small increase in LlC for tracers with larger konBmax or kaff. Note that this pattern is the reverse of that seen for bolus studies (Fig. 4C ). The value of AC was increased by faster tissue-to-blood transport (larger k 2 ) (Fig. 9A) , and lower nonspecific binding (higher f 2 ) ( Fig. 9B) , in a similar manner to bolus studies (Fig. 5) . Unlike bolus studies, the BP that maximized LlC was not greatly affected by k 2 . Across the simulations, BPs of -0.6 to 4 provided contrast within 15% of the maximum AC value. Neurotransmitter competition studies are typically evaluated by estimating the percent change in specific binding between control and stimulus studies. This re quires estimation of the nonspecific fraction, e.g., using a reference tissue region. The percent change in specific binding gives a larger numerical value than � V or �C, the measures used in these simulations. However, we chose to use � V and �C to evaluate the sensitivity to a transient neurotransmitter pulse because it is important to include the relative levels of specific and nonspecific binding in judging the suitability of a tracer for these studies. For example, it would be impractical to have a tracer with a specific binding fraction of only 10% of the total concentration even if it had a 50% change in spe cific binding. In this case, � V would only be 5%, indi cating that it would be difficult to measure the change in signal. In fact, the simulations revealed that the largest changes in specific binding corresponded to tracers with the smallest BP (data not shown), i.e., tracers with the smallest specific binding fractions. Thus it is misleading to conclude that a tracer is sensitive to changes in neu rotransmitter concentration based on a large percent change in specific binding only. The magnitude of � V or �C is a better predictor of which tracers will yield mea surable signals.
Characterizing the bolus method
Methods used for quantification of the distribution volume (e.g., Logan graphical analysis) inherently as- The effect of binding potential on the maximum percent reduction in tissue concentration (�C) measured with the 8/1 method. 8/1 studies were simulated with Nf(t) = J<l;exp(-0.06t}, 10. = 1.0 min-1, kall = 0.02 to 0.25 min-1, and f2konBmax = 0.1 , 0.2, and 0.5 min-1. Each curve corresponds to a different level of receptor density (kanBmax). Regardless of the value of kanBmaxo �C is maximized at a similar binding potential in an analogous manner to Fig. 4C . Binding potential FIG. 9 . Effects on the maximum percent reduction in tissue con centration (�C) of (A) tissue-to-blood clearance (k2)' and (8) non specific binding (f2). B/I studies were simulated with Nf(t) = �exp(-0.06t) and koff = 0.02 to 0.25 min-1. In Fig. 9A , '2= 1, and konBmax = 0.2 min-1. In Fig. 9B , k2 = 0.4 min-1, and konBmax = 0.4 min-1. The value of �C is increased by faster tissue-to-blood transport and less nonspecific binding, similar to the effects seen for � V measured with the bolus method (see Fig. 5 ).
sume stationarity, i.e., linear time-invariant kinetics. However, with transient neurotransmitter release, the ki netics of a neuroreceptor ligand are nonstationary be cause of the varying level of receptor occupancy. As a result, the distribution volume Vet) varies with time. To understand the quantification of competition studies us ing the bolus method, we must determine the relation between the estimated distribution volume and Vet). At any given time, Vet) for the compartment model in Fig. I is The Voo measure (equation 1), can be shown (Appendix A) to be a time-weighted average of Vet), i.e., Vol. 18. No. 11, 1998 where wet) is a weighting function defined as (5) That is, V 00 is equal to V(t) weighted by the normalized free tracer concentration. This result is similar to that of Huang et al. (1981) for the metabolic rate of glucose measured in fluorodeoxyglucose studies in the presence of a time-varying rate. In that case, the estimated rate is approximately a weighted average of the varying glucose metabolic rate, weighted by the normalized plasma fluo rodeoxyglucose concentration, analogous to equations 4 and 5.
Effects of tracer kinetics on measurement of .:l V
The simulations showed that the magnitude of Ll V, i.e., the sensitivity to a change in neurotransmitter concen tration, was dependent on kinetic properties of the tracer, including k 2 0 flo konBmax, and koff ' To help understand these effects, we use equations 3 and 4 to express Ll Vas
where BPe = f 2 konBmax1koff' and BPs(t) = lf2konBmaxi koff)/(l + Nr<t)IK�) are the binding potentials in the con trol and stimulus studies, respectively. The first compo nent on the right hand side of equation 6, BPJ(l + BPe), is the specific binding fraction. The second component is the effective percent change in specific binding, and de pends on the normalized free tracer concentration, i.e., wet).
To explain the effects of tracer kinetics on Ll V, we must understand the integral in the second component of equation 6. Consider BPe and BPs(t) in a pair of control and stimulus studies (Fig. lOA) . Figure lOB shows an example of the weighting function wet) for a rapidly clearing tracer. From examination of equation 6, Ll V will be larger if the early phase of BPs(t), when it is most different from BPe, is weighted more heavily. The sharp peak in w(t) overlaps the initial decrease in BPs(t), indi cating that this tracer should provide good contrast. The largest possible signal could be obtained if wet) is ap proximately a delta function coincident with peak satu ration. If so, Ll V would correlate best with the peak neu rotransmitter concentration, H. However, because wet) generally has a broad peak, Ll V correlates better with fNt{t) and less so with H.
A useful way to predict the effective percent change in specific binding of different tracers is to display the in tegral of the weighting function W(t) = f�W(T)dT. The tracer that gives strongest weight to the initial decrease in shows that the tracer in Fig. 10B is most sensitive to BPs(t) when w(t) is large, i.e., in the first 10 minutes. (C) Integrated weighting function, W( t) , for tracers with different k2 values. The tracer that gives strongest weight to the early reduction in BPs(t) has W(t) reaching a maximum value of 1 most quickly. As tissue-to-blood clearance (k2) increases, W( t) reaches a maximum value of 1 more quickly, consistent with the result that faster k2 increases � V (see Fig. 5A ). (0) W(t) for tracers with different binding potential. Larger binding potential corresponds to slower tracer clearance, which gives suboptimal weighting of BP s(t). As a result, increasing binding potential does not necessarily increase � V (equation 6), even though the specific binding fraction increases.
BPs(t) is revealed as the tracer having Wct) reach a maxi mum value of I most quickly. Figure lOe shows W(t) curves for tracers with different tissue-to-blood clearance (k2) values. For highest k2 values, Wet) reaches a maxi mum value of 1 more quickly, consistent with the result that faster k2 increases � V (see Fig. SA ). Figure lOD shows that for larger BP, the integrated weighting func tion reaches 1 slowly. In this case, the free tracer con centration is prolonged because the specifically bound pool becomes a significant source of free tracer. In other words, for the high BP case, the tracer dissociates slowly from the receptor, but can then rebind to the receptor, which is now unoccupied because the neurotransmitter pulse has substantially cleared.
Therefore, the relation between � V and BP can be summarized as a product of the competing effects given by the two components of equation 6. A BP too small leads to small � V because of a small specific binding fraction, whereas a BP too large leads to small � V be cause of suboptimal weighting of BPsCt). This is consis tent with the result that � V was largest at an intermediate BP (Fig. 4C ). This also explains how BP values an order of magnitude apart could give similar � V. That is, the competing effects of BP oppose each other such that their product changes slowly as the BP changes. When the change in specific binding rather than total binding is reported, as is usually done in experiments, the contrast will be greater at smaller BP. This follows the results of Price et al. (1997) that the high affinity D2 tracer e 8 F]fallypride gives less contrast than [ II C]raclo pride, which has a lower affinity, and therefore, a smaller BP. Similarly, Fowler et al. (1998) showed that the rap idly clearing tracer [ 1l C]cocaine gives larger contrast in measuring dopamine transporter occupancy than the slower clearing [ II C]d-threo-methylphenidate.
In these simulations, the mono exponential neurotrans mitter pulse was initiated coincident with bolus tracer delivery. Simulations with neurotransmitter release ini tiated from 1 to 30 minutes earlier or later than tracer delivery gave smaller � V (data not shown), in agreement with previous results of Logan et al. (1991) . Evidently, simultaneous tracer delivery and neurotransmitter release provides optimal overlap of w(t) and BPs(t). The drop in � V was larger with neurotransmitter release ini\ia\e� 'a\ -ter tracer delivery than with neurotransmitter release ini tiated before tracer delivery. Therefore, it is better to deliver the stimulus such that neurotransmitter release is induced shortly before arrival of the tracer. This is con sistent with the results of Wong et al . (1997) that delivery of amphetamine 5 minutes before [ l i C]raclopride pro vides maximum contrast. Similarly, Dewey et al. (1991) reported that an acute dose of amphetamine delivered 2 to 3 minutes before e 8 F]-N-methylspiroperidol had a greater effect on tracer binding than amphetamine deliv ered slowly during a 25-minute period. Another factor affecting the weighting fu nction of equation 5 is the plasma input function. In particular, faster plasma clear ance leads to faster tissue clearance, and simulations con firmed that faster plasma clearance causes a more rapid drop in wet) and increased � V values (data not shown).
The weighting fu nction w(t) is derived from the free tracer concentration Cf(t) during the stimulus study. In practice, a control bolus study can be modeled to deter mine the free tracer profile, which could be used to es timate wet). This may provide practical insight as to the utility of the tracer for competition studies. A caveat is that the free tracer profile is different in control and stimulus studies because of the effect of neurotransmitter competition on tracer kinetics. In particular, the presence of a neurotransmitter pulse causes free tracer to initially overshoot, then eventually undershoot, the free tracer profile in a control study. Thus the normalized free tracer concentration in a control study predicts lower sensitivity than would actually be expected in a stimulus study.
Simulations performed by Logan et a! . (1991) for e 8 F]-N-methylspiroperidol indicated that the efflux of tracer from tissue has a significant impact on the sensi tivity of in vivo data to endogenous dopamine levels.
Even though those simulations dealt with an irreversible tracer, the results agree well with our simulation data of Figs. 5A and 9A, which showed that larger k 2 values enhanced � V and �c. The theoretical result given by equations 4 and 5, and illustrated in Fig. 10 , further clari fies the importance of tracer kinetics, and particularly the free tracer concentration, on the sensitivity to changes in neurotransmitter concentration. We found that contrast is maximized at a particular value of koff with slower dissociation rates corresponding to smaller � V or �c. Thus we concluded that tracers that are nearly irreversible will not provide optimal contrast. This apparently conflicts with the conclusion of Morris et a! . (1995) that an irreversible tracer should be most sensitive to changes in dopamine concentration. Their result was determined from using the sum of the squared differences between control and stimulus time-activity curves as a measure for the bolus method, whereas here we used the percent change in the distribution volume.
(Note that V cannot be measured for an irreversible tracer.) Thus, for the irreversible case, the sum of J Cereb Blood Flow Metab, Vol. 18. No. II, 1998 squared differences may be a sensitive measure; how ever, unlike the � V measure, such an approach assumes an identical input function for the control and stimulus studies.
Comparison of methods to estimate V The simulation results showed excellent agreement in the estimates of V and �V given by Voo, vLoo, and V 2. Thus, Vee , vLoo, and V 2 are nearly equivalent even for non stationary kinetics. Furthermore, inspection of the graphical analysis equation revealed that the Logan slope approaches Voo with increasing time (see Appendix B).
This theoretical result is consistent with the smaller stan dard deviation in the percent differences between V 00 and V LOO (4.0%), compared with that between V 00 and Vro (12.5%). The similarity of the estimates indicates that as was determined for V"" the vLoO and V 2 measures are approximately weighted averages of Vet), as given by equations 4 and 5. Because these measures all provide very similar quantification of the system, the simplest method can be used to analyze studies. Thus, Logan graphical analysis, which is a simple linear fit and is the most commonly used in practice, is preferred over the other methods tested if V is the only measure of interest.
The discrepancy in the V and � V estimates given by the one-compartment model (V i ) is not unexpected. Note that even for a stationary system, VI would give an in accurate estimate of V as a result of modeling the tissue kinetics with a single compartment. A single compart ment best approximates the system when the receptor dissociation rate is fast. Accordingly, V I was in better agreement with the other estimates when koff values were large.
Characterizing the BII method
With the BII method, tracer ideally achieves equilib rium levels in plasma and tissue, which leads to straight forward calculation of V from the tissue-to-plasma ratio. An advantage of the BII method is that blood sampling is not required in neurotransmitter competition studies, al though there are reference region methods appropriate for bolus studies that also do not require blood sampling (Hume et aI ., 1992; Watabe et a! ., 1995; Ichise et a! ., 1996; Lammertsma and Hume, 1996) . Here, the initial tissue concentration is used as a reference for measure ment of the percent change in concentration (�C) caused by neurotransmitter release (equation 2). Typically, sev eral data points are averaged to measure the post stimulus concentration, although here we used the mini mum tissue concentration. As discussed above, Vet) changes continuously after neurotransmitter release; therefore, the minimum concentration does not corre spond to a fixed change in V. Because there is no ana lytical solution to the model differential equations, we cannot derive a theoretical expression for CM1N or �c. However, because �C is the change in total concentra-tion, we can consider �C to be the product of two effects, in analogy to equation 6. That is, �C equals the specific binding fraction times the percent change in specific binding.
For the B/I method, the magnitude of the change in specific binding depends on the ability of the tracer to be displaced from receptors and subsequently cleared from tissue. For example, faster tissue-to-blood clearance leads to greater �C (Fig. 9A) . The simulation results also showed that the effect of BP on �C was similar to the effect on � V. This can be explained as a product of competing effects of the BP on �c. Consider that a large BP corresponds to a slow receptor dissociation rate, a fast association rate (konBmaJ, or possibly both. These properties cause tracer to clear slowly; therefore, an in crease in neurotransmitter concentration induces a smaller decrease in specific binding when the BP is large. This explains why a larger BP will not necessarily give a larger �C value even though the specific binding fraction is larger (Fig. 8 ). This also may explain the results of Laruelle et al. (1997) , that [ 1 2 3 I]iodobenzofu ran, a D2 tracer with very high affinity (large BP) was less sensitive to changes in dopamine concentration than e 2 3 I]iodobenzamide, a tracer with lower affinity. Fur thermore, Laruelle et al. (1996) found in human studies that 0.3 mg/kg amphetamine produced an 8% decrease in e 2 3 I]iodobenzamide binding, whereas Breier et al. (1997) showed that a smaller amphetamine dose (0.2 mg/kg) produced a larger decrease (15%) in [ II C]raclo pride binding. This may be because e I Clraclopride has a lower affinity (smaller BP) than e 2 3 I]iodobenzamide.
That �C was maximized at small BP (l to 2) illustrates that the B/I method is more sensitive when used with lower affinity tracers. In addition, a lower affinity has the advantage that the initial equilibrium level can be estab lished more quickly.
Accuracy of the model
The extended model was originally developed to ana lyze [ ll Clraclopride-PET and dopamine-microdialysis data acquired simultaneously (Endres et aI ., 1997) . In the time frame of these experiments (90 minutes), the model was sufficient to describe the time-activity curves. How ever, the assumptions of the model may not be adequate to fu lly describe the true in vivo system. For example, in these simulations a monoexponential curve was used to describe the neurotransmitter pulse, based on microdi alysis measurements in rhesus monkey (Endres et aI ., 1997) . However, the lO-minute microdialysis sampling interval limited our ability to more accurately define the pulse shape.
In these simulations, we have assumed that the base line neurotransmitter concentration is negligible. How ever, if we include a baseline concentration of neuro transmitter, No, it can be shown that the simulation equa-tions are unchanged except that the interpretations of Blll ax and Kg are different. In particular, Blll ax should be interpreted as the initial free receptor concentration B :" ax [Blll uA l + No/Kg)] , and the neurotransmitter affinity Kg should be replaced with Kg + No. Thus, a system with baseline neurotransmitter is mathematically equivalent to a system with zero baseline concentration, but with a smaller receptor density and lower affinity. Therefore, the presence of baseline neurotransmitter may be ex pected to lower � V and �C because the neurotransmitter pulse is less potent.
Another factor not included in the model is the pres ence of multiple receptor affinity states for neurotrans mitter binding. In that case, the observed response (�V and �C) would be a weighted sum of the response of the individual affinity states, in which the weight is the pro portion of receptors in each affinity state. Thus with a combination of high and low affinity states, the resulting curves in Figs. 3 and 6 would still show a monotonic relationship with JNit), but the shape would be more complicated because it would ret1ect the weighted sum of two curves. Because the optimal binding potential values for bolus and B/I studies were found to be inde pendent of the pulse size, these values should be un changed by the presence of multiple affinity states.
In B/I simulations, the model predicts that after clear ance of the neurotransmitter pulse, the tracer concentra tion will eventually return to its initial equilibrium level (Fig. 2) . The return to the initial concentration has not been seen in PET studies, possibly because the scan time is too short to observe this effect. However, SPECT stud ies using much longer scans indicate that the reduction in tracer concentration lasts for several hours (Malison et aI ., 1995; Laruelle et aI ., 1997) , which is considerably longer than expected. The prolonged reduction may be caused by receptor internalization, or could be an effect of multiple affinity states for neurotransmitter binding (Larue lie et aI ., 1997). This may indicate that modifica tion of the extended model is likely to be necessary to fully describe neurotransmitter competition.
Signal-to-noise issues
This simulation study was concerned with describing the tissue signal (�V or �C) in terms of neurotransmitter release and the kinetic characteristics of the tracer. For this purpose, the effect of measurement noise was not considered. However, maximizing � V or �C is not equivalent to optimizing contrast in a signal-to-noise sense, because there are situations when a smaller signal can be measured more reliably than a larger signal. For example, the simulations showed that faster tissue-to blood transport (k 2) improves sensitivity. However, faster tissue clearance also reduces tissue radioactivity, which would increase measurement noise. In addition, the half-life of the radioisotope used, the total dose de-livered, and the rate of peripheral metabolism and clear ance affect the noise properties of a tracer. Thus, the guidelines shown here may be most useful in comparing a class of receptor-binding analogs that differ in affinity or nonspecific binding levels in the tissue, but are labeled with the same isotope and have similar peripheral clear ance and metabolism, i.e., the tracers have similar input functions and produce similar image noise levels.
The choice of optimal experimental design, i.e., bolus versus BII, must be considered carefully. One advantage of the bolus technique is that the entire time-activity curve contributes to the measurement, rather than just a few scans at equilibrium. With the B/I method, there may not be sufficient time to reach equilibrium, which would bias the estimate of �c. Advantages of the B/I method are that it only requires a single radiotracer synthesis, and involves a shorter total study duration. In comparison of the measures obtained with each method, the bolus signal (�V) was larger than the B/I signal (�C) for BP greater than 1. The measures were comparable at smaller BP, with �C being slightly larger than � V for BP less than I.
Thus for a rapidly reversible tracer such as [II Clraclo pride, the simulations predict that � V will be larger than �c. This agrees with the results of amphetamine-induced changes in the specific binding of [II Clraclopride as measured with both the bolus and BII methods (Carson et aI ., 1997) . However, the effects of noise and model ac curacy need to be considered more fully to determine whether to use the bolus method or the infusion method to study neurotransmitter competition with a particular tracer. Most important is that the simulation results in dicate that both the bolus and B/I methods yield mea sures that are highly correlated with the underlying changes in neurotransmitter concentration.
APPENDIX A
Consider a bolus injection study for a stationary sys tem, i.e., a system with time-invariant kinetics. In such a study, the total volume of distribution (V) is constant and can be calculated in a variety of ways. Classically (Las sen and Perl, 1979), V can be determined by V,, :
For a bolus study in a non stationary system, the right hand side of equation A 1 can still be calculated, but the result can no longer be interpreted as a fixed distribution volume. In this appendix, we derive the relation between 
Thus, V ", is equal to the average of Vet) as weighted by the normalized free tracer concentration. This indicates that v'" will be more heavily weighted toward the values of Vet) when C[ is at its peak, e.g., near the beginning of a bolus study.
APPENDIX B
The graphical analysis procedure (Logan et aI ., 1990) In a constant infusion study, when equilibrium is reached, 'Y(t) = 0, then equation B3 gives VL(t) = C/C p ' In a bolus study, as t -7 00 and C p and Ci approach zero, equation B3 gives VL(t) == V= (equation 1). To approxi mate VL(t) at earlier times, changing the bounds of inte gration of equation B3 -[31 and it can be shown that the terms in parentheses in equation B4 equal zero, therefore, VL becomes equiva lent to V x' If an initially non stationary system becomes stationary over time, e.g., neuroreceptor binding after clearance of a transient neurotransmitter pulse, then equation B8 will still be valid. Therefore, after a time in which equation B8 is satisfied, VL provides an estimate that is approximately equal to V".
